Funder
Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Dreyling M, Ghielmini M, Rule S, et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(3):298–308.
2. Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol. 2020;95(3):316–27.
3. Kaseb H. AMA, Koshy N. V. Follicular Lymphoma 2022 [Available from: https://www.ncbi.nlm.nih.gov/books/NBK538206/. Accessed 12 Apr 2024.
4. National Cancer Institute. Cancer Stat Facts: NHL—Follicular Lymphoma: Surveillance, Epidemiology, and End Results Program; 2020 [Available from: https://seer.cancer.gov/statfacts/html/follicular.html. Accessed 12 Apr 2024.
5. Wagner-Johnston ND, Link BK, Byrtek M, et al. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood. 2015;126(7):851–7.